Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07644091 · ClinicalTrials.gov registry record
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients
A clinical trial, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 150
- Enrollment target
NCT07644091: Recruiting study, sponsored by Methodist Health System.
NCT07644091 is a clinical trial that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07644091 is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
Assess caregiver psychosocial burden, including Quality of Life, health, interpersonal relationship, access to support, and explore associated sociodemographic and contextual factors.
Primary Outcome
Quality of Life score from the World Health Organization Quality of Life Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-05-26 |
| Est. Completion | 2028-05 |
What NCT07644091 shows while recruiting
NCT07644091 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07644091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07644091 about?
NCT07644091 is a clinical study titled "Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients". Assess caregiver psychosocial burden, including Quality of Life, health, interpersonal relationship, access to support, and explore associated sociodemographic and contextual factors.
What is the current status of trial NCT07644091?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2026-05-26. Estimated completion is 2028-05.
Who is sponsoring clinical trial NCT07644091?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI